FDA Inspection 1180916 — Novum Pharmaceutical Research Services Inc
The FDA completed an inspection of Novum Pharmaceutical Research Services Inc on Sep 9, 2022 in Las Vegas, NV. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 9, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Las Vegas, NV (United States)
Additional Details
Clinical BA/BE